Diabetes Drug Class May Affect COVID19 Outcomes – Endocrinology Advisor

In particular, the investigators set out to evaluate the association of premorbid use of GLP1-RA and SGLT2i with COVID19 outcomes compared with a …

  • You already voted!
  • Read More

Get Unlimited Free Access

Join 20,000 other readers who rate their headlines through us